Emerging Biomarkers in Acute Coronary Syndromes – A Pathophysiologic Perspective - 17/05/22
Abstract |
Diagnosis and prognostication in acute coronary syndromes (ACS) is achieved using a combination of clinical factors and biomarkers, notably cardiac troponin and B type natriuretic peptide and its N terminal fragment NT-proBNP. However, there are numerous biomarkers that have been shown to be associated with ACS, with variable incremental utility. This brief review focusses on some promising emerging biomarkers in ACS, discussed according to pathophysiologic mechanism, as well as diagnostic and prognostic utility.
Le texte complet de cet article est disponible en PDF.Keywords : Biomarker, Acute coronary syndrome, Prognosis, Risk prediction, Pathophysiology
Plan
Vol 31 - N° 6
P. 779-786 - juin 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?